Difference between revisions of "Main Page"
From DolceraWiki
Amika.sethi (Talk | contribs) (→Technology) |
Amika.sethi (Talk | contribs) (→Technology) |
||
Line 116: | Line 116: | ||
* [[Rx to OTC Switch-Market Analysis]] | * [[Rx to OTC Switch-Market Analysis]] | ||
* [[Vaccines Market in Western Countries]], Company Profile:[http://dolcera.com/wiki/index.php?title=GlaxoSmithKline_profile GlaxoSmithKline] | * [[Vaccines Market in Western Countries]], Company Profile:[http://dolcera.com/wiki/index.php?title=GlaxoSmithKline_profile GlaxoSmithKline] | ||
− | |||
* [[Ureteral Stent - Market Analysis]], Company Profile:[[Boston Scientific - Company Profile |Boston Scientific ]] | * [[Ureteral Stent - Market Analysis]], Company Profile:[[Boston Scientific - Company Profile |Boston Scientific ]] | ||
| valign=top | | | valign=top | |
Revision as of 21:26, 31 July 2011
Intellectual Property(IP) Services
Business and Information Research Services
Dolcera Technology Platform
Intellectual Property (IP) Services
Clinical Trial Database
Business & Information Research Services
Dolcera Technology Platforms
Dashboard 1.1Workflow for creating a DashboardIP and Products dashboard
Patent-pathway mappingSequence dashboardDesign analysisInnovation explorerKPort |
Dolcera Offerings summary
Technology Support
Like any of these sample reports?
These are sample reports with brief analysis
Dolcera can provide a comprehensive report customized to your needs
Contact Dolcera |
---|
Samir Raiyani |
Email: info@dolcera.com |
Phone: +1-650-269-7952, +91-40-2355-3493 |